NEXTGEN HEALTHCARE INC (NXGN) Fundamental Analysis & Valuation

NASDAQ:NXGN • US65343C1027

Current stock price

23.94 USD
+0.03 (+0.13%)
At close:
23.93 USD
-0.01 (-0.04%)
After Hours:

This NXGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NXGN Profitability Analysis

1.1 Basic Checks

  • In the past year NXGN was profitable.
  • NXGN had a negative operating cash flow in the past year.
  • NXGN had positive earnings in 4 of the past 5 years.
  • NXGN had a positive operating cash flow in each of the past 5 years.
NXGN Yearly Net Income VS EBIT VS OCF VS FCFNXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

1.2 Ratios

  • NXGN's Return On Assets of -0.72% is fine compared to the rest of the industry. NXGN outperforms 78.57% of its industry peers.
  • The Return On Equity of NXGN (-1.47%) is better than 78.57% of its industry peers.
  • With a decent Return On Invested Capital value of 0.82%, NXGN is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for NXGN is significantly below the industry average of 7.41%.
Industry RankSector Rank
ROA -0.72%
ROE -1.47%
ROIC 0.82%
ROA(3y)0.48%
ROA(5y)1.41%
ROE(3y)0.64%
ROE(5y)2.06%
ROIC(3y)1.91%
ROIC(5y)2.95%
NXGN Yearly ROA, ROE, ROICNXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.06%, NXGN is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of NXGN has declined.
  • NXGN has a Gross Margin of 46.40%. This is comparable to the rest of the industry: NXGN outperforms 42.86% of its industry peers.
  • NXGN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.06%
PM (TTM) N/A
GM 46.4%
OM growth 3Y-58.31%
OM growth 5Y-27.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-2.66%
NXGN Yearly Profit, Operating, Gross MarginsNXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NXGN Health Analysis

2.1 Basic Checks

  • NXGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NXGN has been reduced compared to 1 year ago.
  • The debt/assets ratio for NXGN is higher compared to a year ago.
NXGN Yearly Shares OutstandingNXGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
NXGN Yearly Total Debt VS Total AssetsNXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

  • NXGN has an Altman-Z score of 3.59. This indicates that NXGN is financially healthy and has little risk of bankruptcy at the moment.
  • NXGN has a better Altman-Z score (3.59) than 78.57% of its industry peers.
  • A Debt/Equity ratio of 0.63 indicates that NXGN is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.63, NXGN is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 3.59
ROIC/WACC0.08
WACC10.14%
NXGN Yearly LT Debt VS Equity VS FCFNXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.52 indicates that NXGN has no problem at all paying its short term obligations.
  • The Current ratio of NXGN (2.52) is comparable to the rest of the industry.
  • NXGN has a Quick Ratio of 2.52. This indicates that NXGN is financially healthy and has no problem in meeting its short term obligations.
  • NXGN has a Quick ratio of 2.52. This is comparable to the rest of the industry: NXGN outperforms 52.38% of its industry peers.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.52
NXGN Yearly Current Assets VS Current LiabilitesNXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NXGN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.33% over the past year.
  • Measured over the past 5 years, NXGN shows a small growth in Earnings Per Share. The EPS has been growing by 6.96% on average per year.
  • Looking at the last year, NXGN shows a quite strong growth in Revenue. The Revenue has grown by 13.25% in the last year.
  • The Revenue has been growing slightly by 4.23% on average over the past years.
EPS 1Y (TTM)33.33%
EPS 3Y5.69%
EPS 5Y6.96%
EPS Q2Q%24%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y6.53%
Revenue growth 5Y4.23%
Sales Q2Q%10.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.15% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.76% on average over the next years.
EPS Next Y14.49%
EPS Next 2Y17.83%
EPS Next 3Y17.28%
EPS Next 5Y17.15%
Revenue Next Year11.2%
Revenue Next 2Y9.22%
Revenue Next 3Y8.41%
Revenue Next 5Y7.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NXGN Yearly Revenue VS EstimatesNXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
NXGN Yearly EPS VS EstimatesNXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. NXGN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.38 indicates a rather expensive valuation of NXGN.
  • Based on the Price/Earnings ratio, NXGN is valued cheaper than 92.86% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of NXGN to the average of the S&P500 Index (25.23), we can say NXGN is valued inline with the index average.
  • The Price/Forward Earnings ratio is 17.59, which indicates a rather expensive current valuation of NXGN.
  • Based on the Price/Forward Earnings ratio, NXGN is valued cheaper than 92.86% of the companies in the same industry.
  • NXGN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.42.
Industry RankSector Rank
PE 21.38
Fwd PE 17.59
NXGN Price Earnings VS Forward Price EarningsNXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NXGN is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.12
NXGN Per share dataNXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • NXGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • NXGN's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.48
PEG (5Y)3.07
EPS Next 2Y17.83%
EPS Next 3Y17.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NXGN Dividend Analysis

5.1 Amount

  • NXGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NXGN Fundamentals: All Metrics, Ratios and Statistics

NEXTGEN HEALTHCARE INC

NASDAQ:NXGN (11/8/2023, 8:00:02 PM)

After market: 23.93 -0.01 (-0.04%)

23.94

+0.03 (+0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-24
Earnings (Next)01-22
Inst Owners0%
Inst Owner Change0%
Ins Owners31.12%
Ins Owner Change0%
Market Cap1.61B
Revenue(TTM)695.05M
Net Income(TTM)-6.21M
Analysts50.77
Price Target24.41 (1.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.71
Dividend Growth(5Y)3.39%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.08%
Min EPS beat(2)6.95%
Max EPS beat(2)23.21%
EPS beat(4)3
Avg EPS beat(4)7.54%
Min EPS beat(4)-6.17%
Max EPS beat(4)23.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.72%
Revenue beat(4)2
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-2.26%
Max Revenue beat(4)2.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.11%
PT rev (3m)16.34%
EPS NQ rev (1m)-2.38%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 21.38
Fwd PE 17.59
P/S 2.31
P/FCF N/A
P/OCF N/A
P/B 3.8
P/tB 94.94
EV/EBITDA 34.12
EPS(TTM)1.12
EY4.68%
EPS(NY)1.36
Fwd EY5.68%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS10.36
BVpS6.31
TBVpS0.25
PEG (NY)1.48
PEG (5Y)3.07
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.47%
ROCE 1.04%
ROIC 0.82%
ROICexc 1.14%
ROICexgc 5.45%
OM 1.06%
PM (TTM) N/A
GM 46.4%
FCFM N/A
ROA(3y)0.48%
ROA(5y)1.41%
ROE(3y)0.64%
ROE(5y)2.06%
ROIC(3y)1.91%
ROIC(5y)2.95%
ROICexc(3y)2.27%
ROICexc(5y)3.46%
ROICexgc(3y)18.71%
ROICexgc(5y)23.54%
ROCE(3y)2.41%
ROCE(5y)3.74%
ROICexgc growth 3Y-50.16%
ROICexgc growth 5Y-31.62%
ROICexc growth 3Y-56.26%
ROICexc growth 5Y-28.38%
OM growth 3Y-58.31%
OM growth 5Y-27.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-2.66%
F-Score2
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA 5.98
Cap/Depr 95.52%
Cap/Sales 5.14%
Interest Coverage 1.1
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.52
Altman-Z 3.59
F-Score2
WACC10.14%
ROIC/WACC0.08
Cap/Depr(3y)75.15%
Cap/Depr(5y)68.18%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3Y5.69%
EPS 5Y6.96%
EPS Q2Q%24%
EPS Next Y14.49%
EPS Next 2Y17.83%
EPS Next 3Y17.28%
EPS Next 5Y17.15%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y6.53%
Revenue growth 5Y4.23%
Sales Q2Q%10.65%
Revenue Next Year11.2%
Revenue Next 2Y9.22%
Revenue Next 3Y8.41%
Revenue Next 5Y7.76%
EBIT growth 1Y-70.75%
EBIT growth 3Y-55.58%
EBIT growth 5Y-24.47%
EBIT Next Year47.96%
EBIT Next 3Y27.47%
EBIT Next 5Y21.11%
FCF growth 1Y-203.01%
FCF growth 3Y-52.24%
FCF growth 5Y-32.4%
OCF growth 1Y-110.78%
OCF growth 3Y-20.1%
OCF growth 5Y-10.01%

NEXTGEN HEALTHCARE INC / NXGN Fundamental Analysis FAQ

What is the fundamental rating for NXGN stock?

ChartMill assigns a fundamental rating of 4 / 10 to NXGN.


Can you provide the valuation status for NEXTGEN HEALTHCARE INC?

ChartMill assigns a valuation rating of 3 / 10 to NEXTGEN HEALTHCARE INC (NXGN). This can be considered as Overvalued.


What is the profitability of NXGN stock?

NEXTGEN HEALTHCARE INC (NXGN) has a profitability rating of 4 / 10.


What is the financial health of NEXTGEN HEALTHCARE INC (NXGN) stock?

The financial health rating of NEXTGEN HEALTHCARE INC (NXGN) is 4 / 10.


How sustainable is the dividend of NEXTGEN HEALTHCARE INC (NXGN) stock?

The dividend rating of NEXTGEN HEALTHCARE INC (NXGN) is 0 / 10 and the dividend payout ratio is 0%.